Myocardial oxygen consumption and perfusion before and after cardiac resynchronization therapy: experimental observations and clinical implications

被引:6
作者
Baller, D
Vogt, J
Lindner, O
Lamp, B
Holzinger, J
Kammeier, A
Wielepp, P
Burchert, W
Horstkotte, D
机构
[1] Heart Ctr N Rhine Westphalia, Dept Cardiol, D-32545 Bad Oeynhausen, Germany
[2] Ruhr Univ Bochum, Heart Ctr N Rhine Westphalia, Inst Mol Biophys Radiopharmacol & Nucl Med, Bad Oeynhausen, Germany
关键词
heart failure; resynchronization therapy; pacing; myocardial oxygen consumption; perfusion; PET;
D O I
10.1016/j.ehjsup.2004.05.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Experimental studies indicated unfavourable effects on myocardial energetics and efficiency under asynchronous ventricular stimulation, also shown for left bundle branch block (LBBB) pattern. We noninvasively analyzed the effects on myocardial oxygen consumption (MVO2), perfusion (MBF) and pressure work efficiency by positron emission tomography (PET) before and after resynchronization therapy (CRT) in 31 patients with dilated cardiomyopathy (DCM) and LBBB. Methods 31 patients (19 mates, 12 females) with DCM were studied at baseline and PET 3-4 months follow-up. Baseline characteristics: age 61 +/- 7 years; NYHA class 3.0 +/- 0.4, ejection fraction 22.1 +/- 7.1%, QRS duration 187 +/- 19 ms. MVO2 and MBF were measured from C-11-acetate kinetics with PET by a one-compartment model. MVO2 and MBF were normalized to rate pressure product (RPP) to account for different pressure loads and predicted energy demands. Results Global MVO2 assessed from C-11-acetate clearance did not change significantly between baseline and follow-up (0.080 +/- 0.015/min vs. 0.082 +/- 0.020/min). RPP-normalized MVO2 significantly decreased after CRT (0.072 +/- 0.018/min) vs. baseline (0.081 +/- 0.017/ min; P < 0.05). Normalized MBF showed a concomitant decrease from 0.51 +/- 0.11 to 0.46 +/- 0.1 mL/min/g; P < 0.05 after CRT. Regional MVO2 significantly decreased in the lateral wall (0.083 +/- 0.020/min) compared to baseline (0.090 +/- 0.018/min; P < 0.05) and increased in the septum (0.081 +/- 0.022/min vs. 0.073 +/- 0.014/min at baseline). Conclusion 1. CRT does not increase absolute global MVO2 in the short-term. 2. RPP-normalized MVO2 even decreased suggesting improved pressure work efficiency. 3. CRT leads to a reverse remodelling of regional myocardial oxygen dysbalance. Q 2004 The European Society of Cardiology. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:D91 / D97
页数:7
相关论文
共 50 条
  • [21] Predicting patient response to cardiac resynchronization therapy by gated SPECT myocardial perfusion imaging
    Chen JiYuan GengbiaoYan QingboWang JinjunDepartment of RadiologyEmory University School of MedicineGA USADepartment of Nuclear MedicineSecond Affiliated HospitalChongqing Medical UniversityChongqing China
    重庆医学, 2011, 40 (08) : 790 - 794
  • [22] Myocardial substrate after cardiac resynchronization therapy and the risk of ventricular arrhythmias
    Malhotra, Saurabh
    JOURNAL OF NUCLEAR CARDIOLOGY, 2017, 24 (04) : 1289 - 1291
  • [23] Diastolic dyssynchrony assessment by gated myocardial perfusion-SPECT in subjects who underwent cardiac resynchronization therapy
    Alexanderson-Rosas, Erick
    Espinola-Zavaleta, Nilda
    Garcia, Ernest V.
    Peix, Amalia
    Massardo, Teresa
    Pabon, Luz M.
    Antonio-Villa, Neftali Eduardo
    Carvajal-Juarez, Isabel
    Mesquita, Claudio T.
    Jimenez-Heffernan, Amelia
    Patel, Chetan
    Karthikeyan, Ganesan
    Kumar, Alka
    Butt, Sadaf
    Kalaivani, Mani
    Marin, Victor
    Morozova, Olga
    Paez, Diana
    JOURNAL OF NUCLEAR CARDIOLOGY, 2021, 28 (04) : 1413 - 1421
  • [24] Prognostic implications of mitral regurgitation in patients after cardiac resynchronization therapy
    Cipriani, Manlio
    Lunati, Maurizio
    Landolina, Maurizio
    Proclemer, Alessandro
    Boriani, Giuseppe
    Ricci, Renato P.
    Rordorf, Roberto
    Matassini, Maria Vittoria
    Padeletti, Luigi
    Iacopino, Saverio
    Molon, Giulio
    Perego, Giovanni B.
    Gasparini, Maurizio
    EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 (08) : 1060 - 1068
  • [25] Hyperuricemia predicts adverse clinical outcomes after cardiac resynchronization therapy
    Perge, Peter
    Boros, Andras M.
    Zima, Endre
    Geller, Laszlo
    Merkely, Bela
    Szeplaki, Gabor
    SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2018, 52 (05) : 250 - 255
  • [26] Clinical Implications of Device- Detected Atrial Fibrillation in Cardiac Resynchronization Therapy
    Yoon, Minjae
    Oh, Jaewon
    Chun, Kyeong-Hyeon
    Yu, Hee Tae
    Lee, Chan Joo
    Kim, Tae-Hoon
    Pak, Hui-Nam
    Lee, Moon-Hyoung
    Joung, Boyoung
    Kang, Seok-Min
    KOREAN CIRCULATION JOURNAL, 2023, 53 (07) : 483 - 496
  • [27] A Pilot Study Evaluating Daily Physical Activity Before and After Cardiac Resynchronization Therapy
    Sherry, Daisy
    Knight, Bradley P.
    Casey, Cash
    Larson, Janet
    Hacker, Eileen D.
    Quinn, Lauretta T.
    Wang, Edward
    Collins, Eileen G.
    BIOLOGICAL RESEARCH FOR NURSING, 2014, 16 (01) : 31 - 37
  • [28] RNA-Seq Analysis of Peripheral Blood Monocyte Gene Expression Before and After Cardiac Resynchronization Therapy
    Bilchick, Kenneth C.
    Meng, Lingjin
    Garmey, James
    McNamara, Coleen A.
    CIRCULATION, 2015, 132
  • [29] Tissue Doppler predicts long-term clinical outcome after cardiac resynchronization therapy
    Penicka, Martin
    Vanderheyden, Marc
    Geelen, Peter
    Mortier, Linda
    Goethals, Marc
    Verstreken, Sofie
    Karasek, Jiri
    De Bruyne, Bernard
    Bartunek, Jozef
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2008, 124 (01) : 40 - 46
  • [30] Time-dependent benefit of preventive cardiac resynchronization therapy after myocardial infarction
    Barsheshet, Alon
    Moss, Arthur J.
    Eldar, Michael
    Huang, David T.
    Hall, W. Jackson
    Klein, Helmut U.
    McNitt, Scott
    Steinberg, Jonathan S.
    Wilber, David J.
    Zareba, Wojciech
    Goldenberg, Ilan
    EUROPEAN HEART JOURNAL, 2011, 32 (13) : 1614 - 1621